Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 3 institutions in 3 countries.
Teresa AlemánCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.
Nadja A VielotDepartment of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-9004-0609
Roberto HerreraCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.ORCID 0000-0002-9448-1188
Reymundo VelasquezCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.
Tatiana BerriosCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.ORCID 0000-0003-0172-9365
Christian Toval-RuízCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.ORCID 0000-0002-1938-8012
Evert TéllezCenter for Demographic and Health Research, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.
Andres HerreraCenter for Demographic and Health Research, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.
Samir AguilarLocal Comprehensive Health Care System (SILAIS), Department of León, León 00068, Nicaragua.
Sylvia Becker-DrepsDepartment of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Neil FrenchInstitute of Infection Veterinary & Ecological Science, University of Liverpool, Liverpool CH64 7TE, UK.
Samuel VilchezCenter of Infectious Diseases, Department of Microbiology and Parasitology, Faculty of Medical Sciences, National Autonomous University of Nicaragua, León 00068, Nicaragua.
National Autonomous University of Nicaragua · NIUniversity of North Carolina at Chapel Hill · USUniversity of Liverpool · GB
Funding
Nicaraguan Emerging and Endemic Diseases (NEED) Training ProgramD43TW010923 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BECKER-DREPS, SYLVIA IRENE · 2018 to 2023
$1.4M
FIC NIH HHS D43 TW010923Medical Research Council BVNCP2-07Medical Research Council MR/R005974/1National Institute of Allergy and Infectious Diseases K24AI141744
6 · The paper itself
Abstract
Group B
Indexed as
antimicrobial resistancegroup B StreptococcusNicaraguavaccines
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Rectovaginal Colonization with Serotypes of Group B · full record | OpenQuestion